Manufacturers’ Monthly's first Manufacturing Leaders of Innovation event was hosted on 21 July 2016 at Trajan's Global Corporate Headquarters in Melbourne, Australia, and supported by Autodesk.
From Manufacturers' Monthly:
Innovation might be a word some are sick of, but it remains essential for success. Melbourne-based manufacturer Trajan Scientific and Medical shared a few insights into what it involves for them.
Read the full article at Manufacturers' Monthly: How to avoid making buggy whips
Photo: Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical speaking at Manufacturing Leaders of Innovation event.
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.